| # | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. |  ALA4170662 | SFTI-Arg5Nal7 | Ratio Ki | = | 131 | ALA4156164 | Homo sapiens | |||||
| 2. |  ALA4167071 | SFTI-Arg5Bip7 | Ratio Ki | = | 177 | ALA4156164 | Homo sapiens | |||||
| 3. |  ALA4175285 | SFTI-Arg5Gly7 | Ratio Ki | = | 13 | ALA4156164 | Homo sapiens | |||||
| 4. |  ALA4164510 | SFTI-Nal7 | Ratio Ki | = | 191 | ALA4156164 | Homo sapiens | |||||
| 5. |  ALA4172393 | SFTI-Bip7 | Ratio Ki | = | 142 | ALA4156164 | Homo sapiens | |||||
| 6. |  ALA4172833 | SFTI-Phe7 | Ratio Ki | = | 110 | ALA4156164 | Homo sapiens | |||||
| 7. |  ALA4162159 | SFTI-Gly7 | Ratio Ki | = | 37 | ALA4156164 | Homo sapiens | |||||
| 8. |  ALA4176209 | SFTI-Ser7 | Ratio Ki | = | 15 | ALA4156164 | Homo sapiens | |||||
| 9. |  ALA4165595 | SFTI-Asp7 | Ratio Ki | = | 12 | ALA4156164 | Homo sapiens | |||||
| 10. | ALA4170662 | SFTI-Arg5Nal7 | Ki | = | 38 | nM | ALA4156163 | 7.42 | nM | Homo sapiens | ||
| 11. | ALA4167071 | SFTI-Arg5Bip7 | Ki | = | 28 | nM | ALA4156163 | 7.55 | nM | Homo sapiens | ||
| 12. | ALA4175285 | SFTI-Arg5Gly7 | Ki | = | 369 | nM | ALA4156163 | 6.43 | nM | Homo sapiens | ||
| 13. | ALA4164510 | SFTI-Nal7 | Ki | = | 26 | nM | ALA4156163 | 7.58 | nM | Homo sapiens | ||
| 14. | ALA4172393 | SFTI-Bip7 | Ki | = | 35 | nM | ALA4156163 | 7.46 | nM | Homo sapiens | ||
| 15. | ALA4172833 | SFTI-Phe7 | Ki | = | 45 | nM | ALA4156163 | 7.35 | nM | Homo sapiens | ||
| 16. | ALA4162159 | SFTI-Gly7 | Ki | = | 134 | nM | ALA4156163 | 6.87 | nM | Homo sapiens | ||
| 17. | ALA4176209 | SFTI-Ser7 | Ki | = | 335 | nM | ALA4156163 | 6.47 | nM | Homo sapiens | ||
| 18. | ALA4165595 | SFTI-Asp7 | Ki | = | 402 | nM | ALA4156163 | 6.40 | nM | Homo sapiens | ||
| 19. |  ALA453539 | SFTI-1 (dicyclic) | Ki | = | 4960 | nM | ALA4156163 | 5.30 | nM | Homo sapiens | ||
| 20. |  ALA4852387 | 49 | INH | = | 21 | % | ALA4831741 | % | Homo sapiens |
The page will load shortly, Thanks for your patience!